In Vivo Pharma Intelligence | The Growth Path for Drug Discovery Partners
Nov 2022
Originally published by In Vivo Pharma Intelligence on November 15, 2022
James West, Director in Lincoln’s Healthcare Group, explains the key trends and mergers and acquisitions (M&A) dynamics in the drug discovery industry.
Summary
-
James West, Director in Lincoln’s Healthcare Group, shares with In Vivo Pharma Intelligence the key trends and M&A dynamics in the drug discovery industry.
- Sign up to receive Lincoln's perspectives
Share: 
